Alzheimer’s Vaccine Shows Promising Results

December 2, 2018

Alzheimer’s disease (AD) is the most well-known and most common type of age-related dementia. Amyloid deposition and hyperphosphorylation of tau protein are both pathological hallmarks of the AD. Using a triple-transgenic mouse model (3xTg-AD) that develops plaques and tangles in the brain similar to the human AD, we provide evidence that active full-length DNA amyloid-β peptide 1–42 (Aβ42) trimer immunization leads to the reduction of both amyloid and tau aggregation and accumulation.



Dompé is a leading Italian biopharmaceutical company and its main focus is developing innovative treatment solutions for rare, often orphan, diseases.


Huawei Cloud AI Model Accelerates New Drug Discovery

video | September 22, 2022

pre-trained AI models have greatly sped up pharma R&D, with multi-year tasks, such as identify lead compounds,...

Watch Now

Smart Home Care System For The Elderly

video | September 26, 2022

Monitor your loved one in their home without a camera. Closer uses no camera to monitor senior’s health status. Wifi sensing based technology enables to scan the room with a safe way....

Watch Now

CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

video | September 19, 2022

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution - a 2 minute Preview of the Experimental Protocol...

Watch Now

Simplify the Procedure and Minimize the Need for Modifications

video | September 23, 2022

Foreclosed properties can be one of the best ways to get a cheap property, but understanding this murky world can be difficult....

Watch Now